Total Payments
$11,943
2024 Payments
$3,871
Companies
11
Transactions
43
Medicare Patients
176
Medicare Billing
$19,836
Payment Breakdown by Category
Consulting$11,280 (94.5%)
Food & Beverage$662.77 (5.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $11,280 | 8 | 94.5% |
| Food and Beverage | $662.77 | 35 | 5.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| CSL Plasma Inc. | $11,280 | 8 | $0 (2024) |
| Alkermes, Inc. | $248.59 | 11 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $188.49 | 10 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $83.93 | 5 | $0 (2024) |
| Shire North American Group Inc | $37.31 | 2 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $25.23 | 2 | $0 (2022) |
| Neurocrine Biosciences, Inc. | $17.46 | 1 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $17.34 | 1 | $0 (2019) |
| Corium, LLC | $16.03 | 1 | $0 (2024) |
| Ironshore Pharmaceuticals Inc. | $15.64 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,871 | 4 | CSL Plasma Inc. ($3,840) |
| 2023 | $7,520 | 9 | CSL Plasma Inc. ($7,440) |
| 2022 | $41.01 | 3 | Ironshore Pharmaceuticals Inc. ($15.64) |
| 2020 | $38.46 | 3 | Teva Pharmaceuticals USA, Inc. ($14.58) |
| 2019 | $143.38 | 8 | Alkermes, Inc. ($44.54) |
| 2018 | $178.22 | 9 | Alkermes, Inc. ($70.70) |
| 2017 | $150.91 | 7 | Alkermes, Inc. ($95.23) |
All Payment Transactions
43 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/22/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: Central Nervous System | ||||||
| 06/28/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 03/04/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $960.00 | General |
| 01/10/2024 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $2,880.00 | General |
| 11/08/2023 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $1,600.00 | General |
| 11/08/2023 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $640.00 | General |
| 09/27/2023 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $1,280.00 | General |
| 09/25/2023 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $1,440.00 | General |
| 09/23/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: Central Nervous System | ||||||
| 09/04/2023 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $1,280.00 | General |
| 09/04/2023 | CSL Plasma Inc. | — | Consulting Fee | Cash or cash equivalent | $1,200.00 | General |
| 07/29/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $28.39 | General |
| Category: PSYCHIATRY | ||||||
| 01/28/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $26.85 | General |
| Category: CNS | ||||||
| 12/17/2022 | Ironshore Pharmaceuticals Inc. | JORNAY PM (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: Central Nervous Stimulant ADHD | ||||||
| 09/17/2022 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: BH | ||||||
| 04/22/2022 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $12.62 | General |
| Category: NEUROSCIENCE | ||||||
| 02/28/2020 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $12.61 | General |
| Category: NEUROSCIENCE | ||||||
| 02/01/2020 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $11.27 | General |
| Category: CNS | ||||||
| 01/31/2020 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Central Nervous System | ||||||
| 08/30/2019 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: CNS | ||||||
| 07/25/2019 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: PSYCHIATRY | ||||||
| 06/28/2019 | Shire North American Group Inc | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: NEUROSCIENCE | ||||||
| 06/01/2019 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: NEUROLOGY | ||||||
| 05/31/2019 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $12.42 | General |
| Category: Central Nervous System | ||||||
| 04/13/2019 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 20 | 62 | $5,069 | $3,285 |
| 2022 | 3 | 50 | 128 | $9,134 | $6,183 |
| 2021 | 4 | 64 | 123 | $6,627 | $4,489 |
| 2020 | 2 | 42 | 120 | $8,149 | $5,878 |
Total Patients
176
Total Services
433
Medicare Billing
$19,836
Procedure Codes
10
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 20 | 62 | $5,069 | $3,285 | 64.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 25 | 88 | $7,801 | $5,653 | 72.5% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 12 | 21 | $1,148 | $348.02 | 30.3% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 13 | 19 | $184.49 | $181.78 | 98.5% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 22 | 42 | $2,300 | $1,525 | 66.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 14 | 23 | $2,048 | $1,521 | 74.2% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 17 | 38 | $2,084 | $1,250 | 60.0% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 11 | 20 | $194.20 | $194.20 | 100.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 30 | 98 | $7,177 | $5,144 | 71.7% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 12 | 22 | $972.40 | $733.85 | 75.5% |
About Dr. David Champion, M.D
Dr. David Champion, M.D is a Family Medicine healthcare provider based in Brownsville, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1326046004.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Champion, M.D has received a total of $11,943 in payments from pharmaceutical and medical device companies, with $3,871 received in 2024. These payments were reported across 43 transactions from 11 companies. The most common payment nature is "Consulting Fee" ($11,280).
As a Medicare-enrolled provider, Champion has provided services to 176 Medicare beneficiaries, totaling 433 services with total Medicare billing of $19,836. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Brownsville, TX
- Active Since 07/07/2005
- Last Updated 07/21/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1326046004
Products in Payments
- REXULTI (Drug) $170.01
- Aristada 441 mg (Drug) $165.93
- ARISTADA (Drug) $82.66
- VYVANSE (Drug) $62.54
- AUSTEDO (Drug) $44.41
- Austedo XR (Drug) $39.52
- ABILIFY MAINTENA (Drug) $18.48
- INGREZZA (Drug) $17.46
- SPRAVATO (Drug) $17.34
- Azstarys (Drug) $16.03
- JORNAY PM (Drug) $15.64
- PERSERIS (Drug) $12.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Brownsville
Jason Goolsby, Do, DO
Family Medicine — Payments: $55,359
Family Medicine $55,359
Juan Garcia, M.d, M.D
Family Medicine — Payments: $17,044
Family Medicine $17,044
Dr. Carlos Rosas, M.d, M.D
Family Medicine — Payments: $15,030
Family Medicine $15,030
Jose Perez Enriquez, M.d, M.D
Family Medicine — Payments: $11,337
Family Medicine $11,337
Adam English, D.o, D.O
Family Medicine — Payments: $9,758
Family Medicine $9,758
Alberto Almeida, M.d,, M.D,
Family Medicine — Payments: $7,058
Family Medicine $7,058